| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Royalty Pharma Plc (RPRX) has 15 insiders with recent SEC Form 4 filings, including 8 buys and 0 sells. RPRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 941.0K | $47.79M | - | |
| VP | 658.5K | $33.45M | - | |
| Dir | 194.8K | $9.90M | - | |
| Dir | 81.4K | $4.13M | - | |
| ? | 73.1K | $3.71M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2020 | Legorreta Pablo G. | CEO, Chairman Of The Board | Buy | 20,000 | $28.00 | $560,000.00 | New | |
| Jun 18, 2020 | Coyne Terrance P.75 | EVP &CFO | Buy | 2,950 | $28.00 | $82,600.00 | New | |
| Jun 18, 2020 | Hite Christopher | EVP &Vice Chairman | Buy | 70,000 | $28.00 | $1,960,000.00 | New | |
| Jun 18, 2020 | Riggs Rory B67 | Director | Buy | 15,000 | $28.00 | $420,000.00 | New | |
| Jun 18, 2020 | Ford William E | Director | Buy | 1,500,000 | $28.00 | $42,000,000.00 | New | |
| Jun 18, 2020 | Giuliani Mario Germano84 | Director, 10% Owner | Buy | 50,000 | $28.00 | $1,400,000.00 | New |